Summary
Overview
Work History
Education
Skills
Timeline
Generic
Veronica A. Canver

Veronica A. Canver

Chicago

Summary

Strategic marketing professional with robust background in directing and managing large-scale operations, consistently driving success through strategic planning and execution. Adept at implementing innovative solutions that enhance productivity and operational effectiveness. Known for fostering teamwork and adapting to evolving business needs, ensuring alignment with organizational goals.

Overview

21
21
years of professional experience

Work History

Director, Product Management (503 B compounding Injectables)

QUVA PHARMA
08.2024 - 12.2024
  • Drove product portfolio performance, ensuring alignment with budget goals and tracking results
  • Provided forecasting input for S&OP and continually analyze the financial performance of the product portfolio through sales trends, pricing trends and price-volume trends
  • Directed content creation for product landing pages, developed messaging, promotional materials, and presentations, to clearly communicate product value propositions
  • Collaborated with third-party agencies to design and execute successful product campaigns, enhancing performance and visibility

Senior Manager, Launch Excellence-US Hospital Products (Generic and 505 (b)(2) Injectables)

BAXTER INTL
04.2022 - 08.2024
  • Spearheaded the development/dissemination of highly valued new product launches focusing on premixed IV solutions in Baxter's proprietary GALAXY container
  • Lead product teams to develop/execute on launch plans
  • Lead cross functional core team meetings and acted as a key decision maker for the commercial business
  • Partnered with Baxter's Global Pharma business unit on product development activities
  • Continuously improved Baxter's launch process variables and launch playbook, based on best demonstrated practices for new product launch excellence across Baxter's hospital products portfolio
  • Collaborated with creative agencies for the development of communication tools, i.e
  • Sales training tools and customer facing promotional materials
  • Developed key metrics tracking, which included measuring financial performance to LRP
  • Key contributor to the governance process for development, tracking, and metrics of the launch process with key stakeholders
  • Key accomplishment: Recipient of the 2024 BaxStar award for Innovation Impact: Recognized for leading the accelerated launch of the $22M valued daptomycin IV premix solution, effectively addressing a critical unmet need by streamlining the administration process for clinicians

Director, Product Management-Critical Care and Anesthesia (Generic Injectables)

MEITHEAL
01.2021 - 12.2022
  • Identified and evaluated market opportunities within critical care therapeutic categories
  • Properly positioned and developed product portfolio strategy to drive both short and long-term financial success
  • Drove flawless execution surrounding Meitheal's new product launch process and lead the tactical execution of product strategies
  • Managed relationships with alliance partners and contractual obligations of alliance programs
  • Acted as the single point of contact for new product launch process working to meet critical milestones, driving cross-functional communication and collaboration, identifying obstacles impacting launch timelines and developing recommendations to overcome launch challenges

Marketing Manager, Generic Retail and Specialty Injectables

AKORN
01.2015 - 12.2021
  • Lead all planning, development, and implementation of commercial plans for 200+ generic pharmaceutical products
  • Conducted detailed research on retail and specialty market dynamics and pricing trends to ensure commercial plans are properly aligned with sales goals
  • Evaluated up to 60 contract bids weekly to gauge requested capabilities and resources and predict profitability of each bid
  • Formed partnerships with internal teams to collaborate on the development of field communications, marketing programs, and sales collaterals to support a cohesive product strategy
  • Modeled new molecules to provide 'first pass' review for business development opportunities
  • Key accomplishment: Implemented a portfolio wide pricing strategy that resulted in $7.5MM annual savings in wholesaler fees and increased overall margins by 25%

Manager, Generic Pharmaceutical Insights

WALGREENS
01.2011 - 12.2015
  • Identified business opportunities that guaranteed reliable delivery of top-quality generic pharmaceuticals to meet customer demand and ensure cost savings
  • Gave professional insight as a subject matter expert on industry analytics in the global generic pharmaceutical market to help internal teams create sustainable purchasing plans
  • Provided key input for the development of strategic plans for the global joint venture team of the Boots Alliance Development
  • Tracked fluctuations in regulations and litigation and kept teams up to date on any changes that impacted purchasing efforts
  • Key accomplishment: Built a comprehensive scenario-planning pricing model that lead the purchasing team to realize an annual savings of $12MM

Marketing Analyst

FRESENIUS KABI
01.2009 - 12.2011

Competitive Intelligence Analyst

PROACTIVE WORLD WIDE, INC
01.2006 - 12.2009

Production Chemist

ABRAXIS BIOSCIENCE
01.2004 - 12.2006

Education

Bachelor of Arts - Biology

Northwestern University
Evanston, IL
06-2004

Skills

  • Commercial planning
  • Portfolio management
  • Project management
  • Forecasting
  • Market research
  • New product launch
  • Pricing analytics
  • Competitive intelligence
  • Campaign development
  • Sales team training/support
  • Contract/vendor management
  • Pipeline ideation

Timeline

Director, Product Management (503 B compounding Injectables)

QUVA PHARMA
08.2024 - 12.2024

Senior Manager, Launch Excellence-US Hospital Products (Generic and 505 (b)(2) Injectables)

BAXTER INTL
04.2022 - 08.2024

Director, Product Management-Critical Care and Anesthesia (Generic Injectables)

MEITHEAL
01.2021 - 12.2022

Marketing Manager, Generic Retail and Specialty Injectables

AKORN
01.2015 - 12.2021

Manager, Generic Pharmaceutical Insights

WALGREENS
01.2011 - 12.2015

Marketing Analyst

FRESENIUS KABI
01.2009 - 12.2011

Competitive Intelligence Analyst

PROACTIVE WORLD WIDE, INC
01.2006 - 12.2009

Production Chemist

ABRAXIS BIOSCIENCE
01.2004 - 12.2006

Bachelor of Arts - Biology

Northwestern University
Veronica A. Canver